Literature DB >> 28260315

[Chinese expert consensus on hypertriglyceridemia and hypertriglyceridemia-related cardiovascular risk management].

.   

Abstract

Entities:  

Year:  2017        PMID： 28260315     DOI： 10.3760/cma.j.issn.0253-3758.2017.02.008

Source DB:  PubMed          Journal:  Zhonghua Xin Xue Guan Bing Za Zhi        ISSN： 0253-3758


× No keyword cloud information.
  2 in total

1.  [The triglyceride-lowering effects of PCSK9 inhibitor differ in patients with different baseline triglyceride levels].

Authors:  Yanren Peng; Guojun Chen; Hua Zheng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-08-30

2.  Treatment of Chinese Patients with Hypertriglyceridemia with a Pharmaceutical-Grade Preparation of Highly Purified Omega-3 Polyunsaturated Fatty Acid Ethyl Esters: Main Results of a Randomized, Double-Blind, Controlled Trial.

Authors:  Litong Qi; Qiuling Zhang; Zeqi Zheng; Zhaohui Pei; Hong Mao; Tingbo Jiang; Dmitri Kazei; Elke Kahler; Yong Huo
Journal:  Vasc Health Risk Manag       Date:  2021-09-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.